Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.37    -0.03 (-0.68%)
Bid:
4.40
Ask:
4.795
Spread: 0.395 (8.977%)
Market Cap: £27.26m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

ImmuPharma non-exec reduces stake

Mon, 28th Jan 2013 16:06
Dr Ajay Agrawal, Non-Executive Director of ImmuPharma, sold a stack of shares in the AIM-listed drug company, it was announced Monday.Agrawal traded in 62,169 shares at 57p a time on January 24th, pocketing £35,436 before tax. The deal was announced the same day the group said its key scientific collaboration partner and the inventor of ImmuPharma's lead compound, Lupuzor, has confirmed the effectiveness of a product known as Lupuzor peptide P140. Partner CNRS released a statement saying that in a clinical trial involving 149 patients suffering with the Lupus, an autoimmune disease, the peptide was well tolerated by patients and led to a regression of the disease. Top Director BuysBank of America Corp. (BAC) Director name: Mr R David YostAmount purchased: 20,000 @ $11.53 Value: $230,600Magnolia Petroleum (MAGP) Director name: Mr Ronald Sanford HarwoodAmount purchased: 850,000 @ 2.90p Value: £24,650Magnolia Petroleum (MAGP) Director name: Mr Steven Otis SneadAmount purchased: 500,000 @ 2.90p Value: £14,500XCAP Securities (XCAP) Director name: Mr Nitin Parekh Amount purchased: 4,750,000 @ 0.25p Value: £11,875Top Director SellsDomino Printing Sciences (DNO) Director name: Mr Nigel R BondAmount sold: 38,139 @ 648.90p Value: £247,484Experian (EXPN) Director name: Mr Brian Cassin Amount sold: 15,977 @ 1,099.00p Value: £175,587Domino Printing Sciences (DNO) Director name: Mr Andrew C HerbertAmount sold: 23,252 @ 648.90p Value: £150,882Domino Printing Sciences (DNO) Director name: Mr Garry HavensAmount sold: 20,178 @ 648.90p Value: £130,935Immupharma (IMM) Director name: Mr Ajay AgrawalAmount sold: 62,169 @ 57.00p Value: £35,436Entertainment One Ltd. (DI) (ETO) Director name: Mr Robert LantosAmount sold: 19,000 @ 176.00p Value: £33,440

Related News

LONDON MARKET CLOSE: FTSE 100 rises but profit warning rocks WH Smith
5 days ago

LONDON MARKET CLOSE: FTSE 100 rises but profit warning rocks WH Smith

(Alliance News) - The FTSE 100 made steady progress on Wednesday, outperforming US and European peers, despite ongoing tension in the Middle East and ...

WINNERS & LOSERS: WH Smith seeks capital, cuts outlook; Workspace down
5 days ago

WINNERS & LOSERS: WH Smith seeks capital, cuts outlook; Workspace down

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.

LONDON BROKER RATINGS: Deutsche Bank Research raises easyJet to 'hold'
10 Jun 2026

LONDON BROKER RATINGS: Deutsche Bank Research raises easyJet to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Immupharma News

Incanthera names new CEO, secures funding to buy Swiss skincare brand
4 Jun 2026

Incanthera names new CEO, secures funding to buy Swiss skincare brand

(Alliance News) - Incanthera PLC on Thursday appointed a new chief executive, who will provide the company with funding to support a new acquisition.

EARNINGS AND TRADING: Physiomics deal wins; Watkin Jones revenue down
27 May 2026

EARNINGS AND TRADING: Physiomics deal wins; Watkin Jones revenue down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

WINNERS & LOSERS: Ramsdens ups profit view; Reach revenue falls
6 May 2026

WINNERS & LOSERS: Ramsdens ups profit view; Reach revenue falls

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

IN BRIEF: ImmuPharma forecasts "year of delivery" in 2026
9 Apr 2026

IN BRIEF: ImmuPharma forecasts "year of delivery" in 2026

ImmuPharma PLC - London-based specialist drug discovery and development company - Chair Tim McCarthy produces open letter to shareholders, noting that...

ImmuPharma shares rise on patent milestone and "supportive" study
27 Mar 2026

ImmuPharma shares rise on patent milestone and "supportive" study

(Alliance News) - ImmuPharma PLC on Friday announced a "supportive response" to its UK patent application for P140, which was itself supported by "pos...

WINNERS & LOSERS: Publisher Future down after Jefferies downgrade
27 Mar 2026

WINNERS & LOSERS: Publisher Future down after Jefferies downgrade

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

TRADING UPDATES: Goldstone acquires 50% stake in gold explorer Mincorp
17 Mar 2026

TRADING UPDATES: Goldstone acquires 50% stake in gold explorer Mincorp

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

AIM WINNERS & LOSERS: CRISM rises; Intercede warns on earnings miss
17 Mar 2026

AIM WINNERS & LOSERS: CRISM rises; Intercede warns on earnings miss

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.